Rovatirelin Hydrate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameRovatirelin Hydrate
Drug Alias Name洛替瑞林Ravatirelin (former INNM)罗伐替瑞林TSH derivativerovatirelinum +[11
ClassificationSmall molecules
Mechanisms of ActionThyrotropin releasing hormone receptor agonists
TargetsThyrotropin releasing hormone receptor
Therapy Area/IndicationsSpinocerebellar Degenerations
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSpinocerebellar Degenerations

Other Information

ATC CodeN/A
Related LinksKEGG